K P R Mill Ltd (KPRMILL): Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 28, 2025, 2:17 pm

Competitors of K P R Mill Ltd (KPRMILL)

All Competitor Stocks of K P R Mill Ltd (KPRMILL)

Quarterly Result

Last Updated: August 20, 2025, 8:25 am

Below is a detailed analysis of the quarterly data for K P R Mill Ltd (KPRMILL) based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,766.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,769.00 Cr. (Mar 2025) to 1,766.00 Cr., marking a decrease of 3.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,456.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,436.00 Cr. (Mar 2025) to 1,456.00 Cr., marking an increase of 20.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 310.00 Cr.. The value appears to be declining and may need further review. It has decreased from 333.00 Cr. (Mar 2025) to 310.00 Cr., marking a decrease of 23.00 Cr..
• For OPM %, as of Jun 2025, the value is 18.00%. The value appears to be declining and may need further review. It has decreased from 19.00% (Mar 2025) to 18.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 36.00 Cr., marking an increase of 25.00 Cr..
• For Interest, as of Jun 2025, the value is 14.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 53.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 52.00 Cr. (Mar 2025) to 53.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 279.00 Cr.. The value appears to be declining and may need further review. It has decreased from 281.00 Cr. (Mar 2025) to 279.00 Cr., marking a decrease of 2.00 Cr..
• For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 24.00%, marking a decrease of 3.00%.
• For Net Profit, as of Jun 2025, the value is 213.00 Cr.. The value appears strong and on an upward trend. It has increased from 205.00 Cr. (Mar 2025) to 213.00 Cr., marking an increase of 8.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 6.22. The value appears strong and on an upward trend. It has increased from 5.98 (Mar 2025) to 6.22, marking an increase of 0.24.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:02 am

Growth

Last Updated: September 5, 2025, 8:40 am

Balance Sheet

Last Updated: May 13, 2025, 3:15 pm

Below is a detailed analysis of the balance sheet data for K P R Mill Ltd (KPRMILL) based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 34.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 34.00 Cr..
• For Reserves, as of Mar 2025, the value is 4,968.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,324.00 Cr. (Mar 2024) to 4,968.00 Cr., marking an increase of 644.00 Cr..
• For Borrowings, as of Mar 2025, the value is 466.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,158.00 Cr. (Mar 2024) to 466.00 Cr., marking a decrease of 692.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 494.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 347.00 Cr. (Mar 2024) to 494.00 Cr., marking an increase of 147.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 5,962.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,864.00 Cr. (Mar 2024) to 5,962.00 Cr., marking an increase of 98.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 2,461.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,429.00 Cr. (Mar 2024) to 2,461.00 Cr., marking an increase of 32.00 Cr..
• For CWIP, as of Mar 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 118.00 Cr. (Mar 2024) to 40.00 Cr., marking a decrease of 78.00 Cr..
• For Investments, as of Mar 2025, the value is 264.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Mar 2024) to 264.00 Cr., marking an increase of 230.00 Cr..
• For Other Assets, as of Mar 2025, the value is 3,196.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,284.00 Cr. (Mar 2024) to 3,196.00 Cr., marking a decrease of 88.00 Cr..
• For Total Assets, as of Mar 2025, the value is 5,962.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,864.00 Cr. (Mar 2024) to 5,962.00 Cr., marking an increase of 98.00 Cr..

Notably, the Reserves (4,968.00 Cr.) exceed the Borrowings (466.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for K P R Mill Ltd (KPRMILL), here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 23.85. This value is within the healthy range. It has increased from 23.56 (Mar 24) to 23.85, marking an increase of 0.29.
• For Diluted EPS (Rs.), as of Mar 25, the value is 23.85. This value is within the healthy range. It has increased from 23.56 (Mar 24) to 23.85, marking an increase of 0.29.
• For Cash EPS (Rs.), as of Mar 25, the value is 29.93. This value is within the healthy range. It has increased from 29.10 (Mar 24) to 29.93, marking an increase of 0.83.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 146.34. It has increased from 127.51 (Mar 24) to 146.34, marking an increase of 18.83.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 146.34. It has increased from 127.51 (Mar 24) to 146.34, marking an increase of 18.83.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 186.89. It has increased from 177.29 (Mar 24) to 186.89, marking an increase of 9.60.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 38.63. This value is within the healthy range. It has increased from 38.15 (Mar 24) to 38.63, marking an increase of 0.48.
• For PBIT / Share (Rs.), as of Mar 25, the value is 32.55. This value is within the healthy range. It has decreased from 32.61 (Mar 24) to 32.55, marking a decrease of 0.06.
• For PBT / Share (Rs.), as of Mar 25, the value is 31.09. This value is within the healthy range. It has increased from 30.44 (Mar 24) to 31.09, marking an increase of 0.65.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 23.85. This value is within the healthy range. It has increased from 23.56 (Mar 24) to 23.85, marking an increase of 0.29.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.85. This value is within the healthy range. It has increased from 23.56 (Mar 24) to 23.85, marking an increase of 0.29.
• For PBDIT Margin (%), as of Mar 25, the value is 20.67. This value is within the healthy range. It has decreased from 21.51 (Mar 24) to 20.67, marking a decrease of 0.84.
• For PBIT Margin (%), as of Mar 25, the value is 17.41. This value is within the healthy range. It has decreased from 18.39 (Mar 24) to 17.41, marking a decrease of 0.98.
• For PBT Margin (%), as of Mar 25, the value is 16.63. This value is within the healthy range. It has decreased from 17.16 (Mar 24) to 16.63, marking a decrease of 0.53.
• For Net Profit Margin (%), as of Mar 25, the value is 12.76. This value exceeds the healthy maximum of 10. It has decreased from 13.29 (Mar 24) to 12.76, marking a decrease of 0.53.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.76. This value is within the healthy range. It has decreased from 13.29 (Mar 24) to 12.76, marking a decrease of 0.53.
• For Return on Networth / Equity (%), as of Mar 25, the value is 16.29. This value is within the healthy range. It has decreased from 18.47 (Mar 24) to 16.29, marking a decrease of 2.18.
• For Return on Capital Employeed (%), as of Mar 25, the value is 21.45. This value is within the healthy range. It has decreased from 23.33 (Mar 24) to 21.45, marking a decrease of 1.88.
• For Return On Assets (%), as of Mar 25, the value is 13.67. This value is within the healthy range. It has decreased from 13.73 (Mar 24) to 13.67, marking a decrease of 0.06.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.01, marking a decrease of 0.05.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.09. This value is within the healthy range. It has decreased from 0.26 (Mar 24) to 0.09, marking a decrease of 0.17.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.08. It has increased from 1.06 (Mar 24) to 1.08, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 4.29. This value exceeds the healthy maximum of 3. It has increased from 2.89 (Mar 24) to 4.29, marking an increase of 1.40.
• For Quick Ratio (X), as of Mar 25, the value is 1.88. This value is within the healthy range. It has increased from 1.14 (Mar 24) to 1.88, marking an increase of 0.74.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.05. This value is below the healthy minimum of 4. It has increased from 1.83 (Mar 24) to 2.05, marking an increase of 0.22.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.96. This value is within the healthy range. It has increased from 19.09 (Mar 24) to 20.96, marking an increase of 1.87.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 16.70. This value is below the healthy minimum of 20. It has increased from 15.46 (Mar 24) to 16.70, marking an increase of 1.24.
• For Earning Retention Ratio (%), as of Mar 25, the value is 79.04. This value exceeds the healthy maximum of 70. It has decreased from 80.91 (Mar 24) to 79.04, marking a decrease of 1.87.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 83.30. This value exceeds the healthy maximum of 70. It has decreased from 84.54 (Mar 24) to 83.30, marking a decrease of 1.24.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 26.53. This value is within the healthy range. It has increased from 17.53 (Mar 24) to 26.53, marking an increase of 9.00.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 17.38. This value is within the healthy range. It has increased from 11.83 (Mar 24) to 17.38, marking an increase of 5.55.
• For Enterprise Value (Cr.), as of Mar 25, the value is 31,150.75. It has increased from 29,437.69 (Mar 24) to 31,150.75, marking an increase of 1,713.06.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.88. This value exceeds the healthy maximum of 3. It has increased from 4.86 (Mar 24) to 4.88, marking an increase of 0.02.
• For EV / EBITDA (X), as of Mar 25, the value is 23.59. This value exceeds the healthy maximum of 15. It has increased from 22.58 (Mar 24) to 23.59, marking an increase of 1.01.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.85. This value exceeds the healthy maximum of 3. It has increased from 4.70 (Mar 24) to 4.85, marking an increase of 0.15.
• For Retention Ratios (%), as of Mar 25, the value is 79.03. This value exceeds the healthy maximum of 70. It has decreased from 80.90 (Mar 24) to 79.03, marking a decrease of 1.87.
• For Price / BV (X), as of Mar 25, the value is 6.20. This value exceeds the healthy maximum of 3. It has decreased from 6.53 (Mar 24) to 6.20, marking a decrease of 0.33.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.85. This value exceeds the healthy maximum of 3. It has increased from 4.70 (Mar 24) to 4.85, marking an increase of 0.15.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness